Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Subacromial Injection With Glutamate Receptor (NMDAR) Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?

NCT02967640 is registered in ClinicalTrials.gov with Helse Møre og Romsdal HF as lead sponsor.

NCT NCT02967640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Subacromial Injection With Glutamate Receptor (NMDAR) Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?
Lead sponsor
Helse Møre og Romsdal HF
Phase
Phase 2/3
Overall status
Completed
Start date
May 30, 2018
Completion date
December 30, 2024
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, rotator cuff tendinitis